Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Hemispherx Biopharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

05 Feb 2016 Reuters Investment Profile 12 $20.00

HEB: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

12 Feb 2016 New Constructs, LLC 10 $25.00

Wright Investors Service Comprehensive Report for Hemispherx Biopharma, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Feb 2016 Wright Reports 56 $75.00

Hemispherx BioPharma

06 Feb 2016 S&P Capital IQ Quantitative Report 8 $92.00

HEMISPHERX BIOPHARMA INC (HEB=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

Value Graph: HEMISPHERX BIO -- HEB

05 Feb 2016 Ford Investor Services, Inc. 1 $12.00

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review Summary Hemispherx Biopharma, Inc. (Hemispher...

04 Feb 2016 GlobalData 58 $300.00

Hemispherx BioPharma, Inc: Upgraded to Good

18 Dec 2015 Sadif Analytics Prime 3 $10.00

Thomson Reuters Stock Report - Hemispherx Biopharma Inc (HEB-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

11 Dec 2015 Thomson Reuters Stock Report 11 $25.00

Does Hemispherx BioPharma, Inc Hold Long-Term Value?

08 Dec 2015 Sadif Analytics Prime 12 $25.00